Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
AI in Drug Discovery Has Great Potential – But Also Significant Barriers
Posted on May 1st, 2019 by Nicki Catchpole in Pharma R&D
Elsevier’s Tim Miller’s article in World Pharma Today provides a insightful lens into the reality behind the complexities of implementing artificial intelligence into the R&D cycle. While great strides have been made, the runway to realize the potential is a long one and there are many exciting discoveries left to be made and obstacles to overcome.
(more…)Emulating start-up success with purpose-built data tools
Posted on December 12th, 2018 by Nicki Catchpole in Pharma R&D
Innovation used to be almost solely accredited to Big Pharma, but many of the more established businesses in the industry are finding that their rate of discovery is slowing as they try to find answers to some the industry’s biggest problems, such as antibiotic resistance. (more…)
Finding Answers Where You Least Expect Them
Posted on November 19th, 2018 by Christy J. Wilson in Pharma R&D
The hard work of drug development often goes down well-worn paths that can be tedious, time-consuming and frustrating, but – with time and dedication – can yield exciting results. Sometimes, however, scientists who think outside the box find themselves taking unconventional routes in their efforts to create innovative new therapies. (more…)
Machine Learning Could Make Drug Discovery Faster, Cheaper, Better
Posted on November 6th, 2018 by Jabe Wilson in Pharma R&D
The stats on the increasingly high cost (and low success rates) in drug discovery are always jarring. As Phee Waterfield of Binary District Journal reports:
- Bringing a new drug to market is estimated to cost major pharma firms more than $4 billion
- The process can take 10-15 years
- Fewer than 10% actually make it to market
